Eisai’s Medical Education (ME) Grants Program provides funding in the form of an educational grant to support bona-fide educational programs and activities related to or covering current disease states, patient care, or scientific and medical information. Educational grants must support independent, educational, non-promotional programs and activities, which support health care provider education, advance the quality of patient care, and align with Eisai’s therapeutic or clinical interests.
Detailed submission policies and procedures are posted on this website for your use. If you have any questions regarding the preparation of the application, or are experiencing technical difficulties, please contact the Eisai Grants Department:
Please allow 1 business day for return reply.
Eisai is currently accepting medical education grant applications for the following therapeutic areas:
The Grant Review Committees (Neurology and Oncology) meet on a monthly basis to review eligible requests.
Applications should be submitted at least 45 days prior to the scheduled program or activity or to any applicable submission deadline to which the Requestor is subject. Requests submitted less than 45 days prior to the scheduled program/activity or to any applicable submission deadline to which the ME Requestor is subject will be reviewed at the Committee’s discretion. Requests submitted less than 30 days prior to the scheduled program/activity or to any applicable submission deadline to which the ME Requestor is subject will not be reviewed by the Committee. Grant requests may also be rejected if they are considered to be incomplete.
To begin your application in our grant management system, please create a login and password or enter your existing user name and password.
Please select the therapeutic area for which you are requesting funding to ensure accuracy in tracking your application and to avoid any delays in reviewing the application.
Once the grant application is completed and submitted, you will receive a confirmation along with a tracking number. You may be contacted if there are any questions about the application. The request will then be reviewed by the relevant Medical Education Grants Committee.
Upon completion of review, requestors will be notified of the Committee’s decision via email.
If your application is approved, Eisai will generate a written agreement between Eisai and the applicable requesting organization(s). Upon execution of the agreement, Eisai will arrange to make issuance of payment(s) as per the agreement requirements.
Eisai may provide funding in the form of an educational grant to support bona-fide educational programs and activities which communicate the most current disease awareness, scientific and medical information to the medical and healthcare community to improve patient care.
The Eisai grant approval process is conducted in accordance with the recommendations and mandates of the Office of the Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, the Accreditation Council for Continuing Medical Education (ACCME) Guidelines, the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, as well as internal Eisai policies and other applicable guidelines.
Grant approvals are never related to or otherwise conditioned upon the past, present or future prescribing, purchasing, or recommending of Eisai products and are awarded at Eisai’s sole discretion.
Requestors and organizers of the educational programs or activities must maintain independence and have full control over the delivery and development of the program supported by Eisai. Eisai may not direct or influence the content of the educational program or play any role in the program.
Eisai’s competitive grant program may involve a publicly posted Request for Proposal (RFP) as that need arises, and will be submitted to grant requestor portals as appropriate. The RFP provides details regarding a general area of interest, timelines for review and approval and uses an independent review process to make final grant decisions. Organizations will be invited to apply addressing the specific RFP.
Publically posted RFPs will include release date as well as grant application due dates.
Grant proposals received in response to RFPs during the acceptable time frame will be reviewed by the committee according to the review process described above. The RFP will serve as a tool that will provide a framework for the committee to systematically assess the quality of educational programming being described in the grant requests.
At this time, RFP’s are only available in the Therapeutic Areas for Oncology.